Schedule 13G ownership disclosure

Xenon Pharmaceuticals Inc

Security class unavailable · CUSIP: 98420N105

Event date: 2018-05-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,429,000
Percent of class
10.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-18-000162
Form type
SC 13G/A
Filer
Capital World Investors
CIK
CIK 1422849
Filed
Jun 08, 2018
Reporting period
May 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub